- Home
- Editorial
- News
- Practice Guidelines
- Anesthesiology Guidelines
- Cancer Guidelines
- Cardiac Sciences Guidelines
- Critical Care Guidelines
- Dentistry Guidelines
- Dermatology Guidelines
- Diabetes and Endo Guidelines
- Diagnostics Guidelines
- ENT Guidelines
- Featured Practice Guidelines
- Gastroenterology Guidelines
- Geriatrics Guidelines
- Medicine Guidelines
- Nephrology Guidelines
- Neurosciences Guidelines
- Obs and Gynae Guidelines
- Ophthalmology Guidelines
- Orthopaedics Guidelines
- Paediatrics Guidelines
- Psychiatry Guidelines
- Pulmonology Guidelines
- Radiology Guidelines
- Surgery Guidelines
- Urology Guidelines
Passive smoking causes more stillbirths compared to Active Smoking : BMJ
A new study published in the BMJ journal Tobacco Control reveals that secondhand smoke (SHS) or Passive Smoking causes thousands of stillbirths, more than active smoking in developing countries, especially in Asia.
Exposure to secondhand smoke or Passive Smoking during pregnancy increases the risk of congenital malformations, infant stillbirth, respiratory illnesses, and low birth-weight. However, not much is know about the extent of SHS exposure during pregnancy. Kamran Siddiqi, from the University of York's Department of Health Sciences, and colleagues conducted the study to assess the prevalence of SHS exposure in pregnant women in low-income and middle-income countries (LMICs).
The investigators used Demographic and Health Survey data collected between 2008 and 2013 from 30 LMICs. Weighted country-specific prevalence of SHS exposure was then estimated among 37 427 pregnant women. Associations between sociodemographic variables and SHS exposure in pregnant women using pairwise multinomial regression model were explored.
Key Findings:
- The prevalence of daily SHS exposure during pregnancy ranged from 6% (95% CI 5% to 7%) (Nigeria) to 73% (95% CI 62% to 81%) (Armenia) and was greater than active tobacco use in pregnancy across all countries studied.
- Being wealthier, maternal employment, higher education, and urban households were associated with lower SHS exposure in full regression models.
- 40% of all pregnant women in Pakistan are exposed to secondhand smoke -- causing approximately 17,000 stillbirths in a year.
- Daily SHS exposure accounted for a greater population attributable fraction of stillbirths than active smoking, ranging from 1% of stillbirths (Nigeria) to 14% (Indonesia).
- In Armenia, Indonesia, Jordan, Bangladesh, and Nepal more than 50% of pregnant women reported exposure to household secondhand smoke.
- In Pakistan, only 1% of stillbirths are attributed to women actively smoking during pregnancy, but for secondhand smoke, the figure is 7%, largely due to the high numbers of pregnant women exposed to tobacco smoke in the home.
- In five of the 30 countries, household secondhand smoke exposure was twice as common as active smoking.
Read Also: Prenatal tobacco smoke exposure worse than postnatal smoke exposure
"It was predominately male smokers exposing women to secondhand smoke," said professor Siddiqi.
He said: "This is the first study which provides national estimates for 30 developing countries on secondhand smoke exposure in pregnancy and it reveals a huge problem, a problem which is not being addressed. We have shown for the first time that secondhand smoke during pregnancy is far more common than active smoking in developing countries, accounting for more stillbirths than active smoking."
"We have demonstrated that SHS exposure during pregnancy is far more common than active smoking in LMICs, accounting for more stillbirths than active smoking. Protecting pregnant women from SHS exposure should be a key strategy to improve maternal and child health," concluded the authors.
For more information log on to http://dx.doi.org/10.1136/tobaccocontrol-2018-054288
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd